Date

Monday, 12 April 2021

Location

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

Data characterization and discoverability are goals for the scientific community and for medicines regulation. The HMA-EMA joint Big Data Task Force recommended “to promote data discoverability through the identification of metadata” as part of its Priority recommendations of the HMA-EMA joint Big Data Task Force, which is reflected in the Big Data Steering Group work plan.

The objective of this workshop is to review and gather stakeholders’ feedback on:

  • preliminary list of metadata required for characterising real-world data sources and definitions to fulfil regulatory use cases;
  • proposed options for metadata from real-world data sources collection and maintenance processes;
  • proof-of-concept catalogue of data sources and metadata.

Documents

Multimedia

Share this page